Literature DB >> 8519344

Glycan structure of blood group-A antigen in hamster normal tissues and pancreatic cancers.

M Hirota1, M Mogaki, P M Pour, W G Chaney.   

Abstract

Pancreatic cancers induced by N-nitrosobis(2-oxopropyl)amine in Syrian hamsters produce blood group A antigen. The glycan structure of the blood group A antigen-bearing glycoproteins purified from pancreatic cancer cells has been shown previously to be bound to Asn-linked complex oligosaccharides. Because blood group A antigen has usually been described as being on Ser/Thr-linked glycans, the distribution and glycan-protein linkage of the antigen were examined in normal hamster tissues in comparison with the findings on pancreatic cancer cells. The gastrointestinal tract, excluding the small intestine, expressed blood group A antigen. The liver, pancreas, and gallbladder did not show blood group A reactivity. Blood group A antigen in the proximal gastrointestinal tract was resistant to peptide N-glycosidase F digestion, which cleaves Asn-linked glycans from core proteins. Blood group A antigen was peptide N-glycosidase F sensitive in membrane preparations from pancreatic cancers. In the colon, this antigen was only partially removed by peptide-N-glycosidase F. These results demonstrate a difference in the structure of blood group A antigen-associated glycan between pancreatic cancers and normal hamster gastrointestinal tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8519344     DOI: 10.1006/exmp.1993.1015

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  2 in total

1.  Establishment and characterization of a new, spontaneously immortalized, pancreatic ductal cell line from the Syrian golden hamster.

Authors:  T Takahashi; M P Moyer; M Cano; Q J Wang; T E Adrian; C P Mountjoy; W Sanger; H Sugiura; H Katoh; P M Pour
Journal:  Cell Tissue Res       Date:  1995-10       Impact factor: 5.249

2.  Modification of blood group A expression in human pancreatic tumor cell lines by inhibitors of N-glycan processing.

Authors:  C Schaffert; P M Pour; W G Chaney
Journal:  Int J Pancreatol       Date:  1997-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.